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ABSTRACT:  TDP-43 is a multifunctional RNA-binding protein found to be a major protein 
component of intracellular inclusions found in neurodegenerative disorders such as Fronto 
Temporal Lobar Degeneration, Amyotrophic Lateral Sclerosis, and Alzheimer Disease. PRO-
MINE (PROtein Mutations In NEurodegeneration) is a database populated with manually curated 
data from the literature regarding all TDP-43/TDP43/TARDBP gene disease-associated mutations 
identified to date. A web server interface has been developed to query the database and to provide 
tools for the analysis of already reported or novel TDP-43 gene mutations. As is usually the case 
with genetic association studies, assessing the potential impact of identified mutations is of crucial 
importance, and in order to avoid prediction biases it is essential to compare the prediction results. 
However, in most cases mutations have to be submitted separately to various prediction tools and 
the individual results manually merged together afterwards. The implemented web server aims to 
overcome the problem by providing simultaneous access to several prediction tools and by 
displaying the results into a single output. Furthermore, the results are displayed together in a 
comprehensive output for a more convenient analysis and are enriched with additional information 
about mutations. In addition, our web server can also display the mutation(s) of interest within an 
alignment of annotated TDP-43 protein sequences from different vertebrate species. In this way, 
the degree of sequence conservation where the mutation(s) occur can be easily tracked and 
visualized. The web server is freely available to researchers and can be accessed at 
http://bioinfo.hr/pro-mine. ©2010 Wiley-Liss, Inc. 
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INTRODUCTION 
Genetic association studies aim to elucidate how single nucleotide polymorphisms (SNPs) may be related to a 
genetic predisposition to develop disease. Non-synonymous single nucleotide polymorphisms are a type of SNPs 
that result in a codon which codes for a different amino acid. Some of these polymorphisms are responsible for 
many diseases as they may lead to appreciable changes in protein structure and function. Annotating and 
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distinguishing the polymorphisms that render the protein non-functional from those that do not is essential for the 
study of disease-associated mutations. However, screening the pathogenicity for each identified SNP 
experimentally is often a very laborious task that requires a considerable amount of time. To overcome this 
challenge, several computational approaches for in silico predictions have been developed in recent years, 
reviewed recently by Thusberg and Vihinen (Thusberg and Vihinen, 2009). 
Nuclear factor TDP-43 (TDP43; HGNC-approved symbol TARDBP; MIM# 605078) is an example of a protein 
with high SNP count. TDP-43 is a multifunctional RNA binding protein that plays a role in several cellular 
processes such as transcription, pre-mRNA splicing, mRNA stability and mRNA transport (Buratti and Baralle, 
2008; Buratti and Baralle, 2009; Chen-Plotkin et al., 2010). Recently, TDP-43 has also been found as the major 
protein component of the intracellular inclusions occurring in the neuronal tissues of patients affected by a series 
of neurodegenerative diseases which include Fronto Temporal Lobar Degeneration (FTLD-U), Amyotrophic 
Lateral Sclerosis (ALS) (Geser et al., 2009; Neumann et al., 2006) and in a significant proportion of Alzheimer 
Disease patients (Amador-Ortiz et al., 2007; Bigio, 2008; Rohn, 2008). In affected neurons, TDP-43 is abnormally 
mislocalized to the cytoplasm, ubiquitinated, hyperphosphorylated and cleaved to generate C-terminal fragments 
(Dormann et al., 2009; Hasegawa et al., 2008; Igaz et al., 2008; Neumann et al., 2009; Zhang et al., 2009). For a 
detailed clinical view of TARDBP mutation carriers in the aforementioned diseases the reader is referred to the 
Alzheimer Disease and Frontotemporal Dementia Mutation Database (http://www.molgen.ua.ac.be/ftdmutations) 
and to the Amyotrophic Lateral Sclerosis Online genetic Database (http://alsod.iop.kcl.ac.uk). 
  In the beginning, the question was still open regarding the relative importance of this protein: should TDP-43 
protein inclusions be considered as a simple pathological curiosity of these diseases or did it really play a role in 
their origin and progression (Rothstein, 2007)? The recent development of several animal models, from simple 
organisms to more complex ones, has clearly shown the pathological potential of both TDP-43 depletion and 
overexpression in general (Feiguin et al., 2009; Hanson et al., 2010; Johnson et al., 2008; Kraemer et al., 2010; Li 
et al., 2010; Lu et al., 2009; Sephton et al., 2010; Wils et al., 2010; Wu et al., 2010). 
  Another evidence that TDP-43 misregulation may be the cause of disease has been provided by several 
genetic findings that have identified TDP-43 mutations in about 5% of the patients, as recently reviewed by 
Pesiridis et al. (Pesiridis et al., 2009). With only two exceptions (p.Ala90Val and p.Asp169Gly) all disease-
associated mutations in human TDP-43 are localized in the C-terminal tail of the protein (a region that in hnRNP 
proteins is usually associated with protein-protein interactions) and are all except p.Tyr374X characterized as 
missense mutations (Figure 1). In this respect, it is important to note that all these mutations are dominant traits 
and, until today, in the C-terminal tail no missense mutation has been found in healthy controls. At the moment, 
very little is known about the role potentially played by these mutations. Nonetheless, expression of mutant forms 
of this protein in Mus musculus (Wegorzewska et al., 2009), Rattus norvegicus (Zhou et al., 2010), Danio rerio 
(Kabashi et al., 2010), Gallus gallus (Sreedharan et al., 2008), Saccharomyces cerevisiae (Johnson et al., 2009) 
and neuronal cell lines (Barmada et al., 2010; Nonaka et al., 2009) can reproduce neurodegenerative effects similar 
to those observed in human disease. 
 
 
Figure 1. TDP-43 disease-associated mutations. The diagram shows the distribution of all missense mutations associated with 
disease along the TDP-43 protein: all mutations are reported in the C-terminal tail of the protein with the exception of 
p.Ala90Val and p.Asp169Gly (see Database and Analysis Tools section for details about the nomenclature used for mutations). 
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Here we present PRO-MINE (PROtein Mutations In NEurodegeneration), a manually curated mutation 
repository providing detailed and updated information from the literature focusing on the potential functional 
consequences of the TARDBP gene mutations. 
We designed and implemented a user-friendly web interface aimed to facilitate the access to the database and to 
integrate multiple prediction tools for the analysis of mutations. The results from the prediction tools are 
automatically retrieved into a single output, greatly reducing the amount of time required when studying the effects 
of mutations on protein. Furthermore, based on the fact that knowledge regarding the functional consequences of a 
mutation can also be gained from sequence comparison, PRO-MINE also offers the possibility to display an 
aligned set of protein sequences from several vertebrate species with the mutations of interest distinctly annotated. 
PRO-MINE represents a novel approach and an advantage upon other existing tools and provides the proof of 
concept for the need to generally integrate data with computational analytical tools in the study of mutations. 
DATABASE AND ANALYSIS TOOLS 
PRO-MINE database 
PRO-MINE is a relational database of published disease-associated mutations in human neurodegenerative 
diseases, in particular focusing on the TARDBP gene. 
The database was created using MySQL and consists of the following tables: mutations, genes and exons. The 
entity relationships of the three tables are depicted in Figure 2. The conceptual scheme described was designed to 
make easier future inclusion of other relevant genes and associated mutations. The database stores not only 
information related to the mutations identified in the human TARDBP gene but also protein and genomic data 
associated with the gene itself. 
 
 
Figure 2. Entity relationship diagram of the PRO-MINE database. The scheme 
illustrates the tables created for data storage (mutations, genes and exons) with the 
respective attributes and how they are connected. The simple relationships between 
the tables facilitate the possible expansion of the database to other proteins involved 
in neurodegeneration. 
 
An exhaustive manual review of the literature and public repository databases regarding TARDBP gene 
mutations was performed. The result was a curated set of 43 mutations representing the most exhaustive to date 
status of identified and characterized TDP-43 gene mutations, further referred to as ‘TDP-43 mutations core set’. 
Relevant information concerning the mutations was, wherever available, extracted from the literature and included 
in the mutations table. The information provided about a given mutation for each entry of the mutations table 
includes: (1) the exon number where the mutation occurs; (2) clinical information related to the mutation such as 
the number of patients where it was identified (in case of mutations found in different affected family members 
only one patient for family was computed), the phenotype presented by the patients or the onset site of the disease; 
(3) a brief description of observed experimental evidences on the functional consequences of the mutation on a 
protein; and (4) references to original papers that reported the mutation as well as later studies. The mutation 
nomenclature complies with the accepted guidelines proposed by the Human Genome Variation Society TDP-43 Mutation Database  E1951 
 
(http://www.hgvs.org/mutnomen) and the variants numbering system is given on the protein level relative to the 
amino acid reference sequence. 
Protein sequences and genomic data stored in the genes and exons tables were retrieved from Ensembl (release 
57 – Mar 2010) (Hubbard et al., 2009) through its Perl Application Program Interface. The set of protein sequences 
comprises the human protein sequence encoded by the TARDBP gene (RefSeq NM_007375.3) and its orthologs 
from six vertebrates: Pan troglodytes, Mus musculus, Rattus norvegicus, Gallus gallus, Xenopus tropicalis and 
Danio rerio. 
PRO-MINE web server interface implementation 
The PRO-MINE web server is intended to facilitate the access to the data stored in the database and to provide 
means for its analysis. The web server interface consists of dynamically generated HTML pages and was 
developed using Perl CGI scripts (http://www.perl.com). The scripting programs run on Apache web server and 
use MySQL (http://www.mysql.com) to retrieve and manage information stored in the database. 
Analysis Tools 
The PRO-MINE web server integrates four available software tools – NetPhos 2.0 (Blom et al., 1999), 
PolyPhen (Ramensky et al., 2002), SIFT (Ng and Henikoff, 2003) and SNAP (Bromberg and Rost, 2007) – to 
predict the pathological character of a mutation on a protein. The prediction tools were obtained as stand-alone 
software packages (free for academic use) and integrated into the PRO-MINE web server with custom Perl scripts. 
The integration of the prediction tools serves the purpose of providing researchers with a layout for a more 
convenient and faster analysis of the results attained. 
The four software tools use different models and features to predict the functional effect of mutations on 
protein. NetPhos uses sequence and structure-based neural networks for predicting phosphorylation sites at serine, 
threonine or tyrosine residues in protein sequences based on the premise that creation of new phosphoylation sites 
or disruption of existing ones can alter the functionality of a protein. Although in normal conditions TARDBP does 
not seem to be heavily phosphorylated, one of the distinguishing features of this disease-related protein is that it 
becomes phosphorylated at several residues in the C-terminal region (Hasegawa et al., 2008; Neumann et al., 
2009). Therefore, prediction of phosphorylation sites should be taken into consideration because the aberrant 
phosphorylation in the C-terminal region of TARDBP may be very important with regards to altering its 
functionality. PolyPhen algorithm applies straightforward empirical rules to sequence-based, structural and 
phylogenetic parameters describing the mutation. SIFT is an evolutionary-based approach which relies solely on 
the information extracted from a multiple alignment of homologous proteins and the physical properties of amino 
acids to calculate the probability that a mutation will be tolerated. Finally, SNAP combines information derived 
from sequence homology and protein properties (secondary structure, solvent accessibility, etc) into neural 
networks.  The reason for the use of complementary approaches lies with different strengths and weaknesses of 
various prediction algorithms, and in the absence of experimental evidence, the best strategy is to apply a 
consensus decision among as many prediction tools as possible.  
Besides these analysis tools available for user selection, PRO-MINE uses the multiple alignment software for 
protein and nucleotide sequences – MUSCLE (Edgar, 2004) – in the internal pipeline. MUSCLE is employed in 
the protein sequence annotation analytical tool to perform on-the-fly multiple alignments of homologous protein 
sequences. 
DISCUSSION 
Bioinformatics methods are of great help in elucidating the potential functional impact of mutations on protein 
since they provide quick and accurate predictions. Nonetheless, each of the methods applies different features and 
algorithms in the prediction analysis and, as a consequence, different results might arise. This poses a challenge for 
the choice of the best method to utilize. As intuitively obvious, the best strategy to overcome this problem is to use 
several prediction methods at the same time and to take into account all the results with the purpose of obtaining a 
more reliable evaluation. However, manual inspection and analysis of the results from several bioinformatics tools 
is a time-consuming procedure that requires parallel submission of the mutations of interest to each prediction 
server separately and manual combining of the resulting predictions afterwards. Usually, these tools require 
different input formatting and structure their output in different ways, and it is often impractical and time-E1952  Pinto et al. 
consuming for the user to collect the data and integrate it in the proper context. Also, knowledge discovery process 
requires the researcher to use additional information sources and analysis tools. 
In the PRO-MINE database and analysis server, the data and analysis tools are integrated in a user-friendly 
interface in order to shift the focus of the researcher towards the problem and away from manual tasks of data 
manipulation. Besides the manually curated database of known TDP-43 mutations, the analysis functions 
implemented in PRO-MINE include: (a) prediction of mutational effects on protein function and (b) protein 
sequence annotation with mutations. Details on the usage and currently available options are described below. The 
developed web tool is freely available at: http://bioinfo.hr/pro-mine. 
Input 
The web server accepts as input a list of mutations which can be typed directly into the query input box or 
uploaded as a simple text file (Figure 3a). Mutation nomenclature should follow the standard protein mutation 
format: XposY, where X and Y are the two amino acid variants (wild-type and mutant, respectively) and pos is the 
position of the substitution in the sequence (e.g., M337V). The server also offers the possibility of using the TDP-
43 mutations core set by simply selecting the corresponding checkbox. Additionally, both fields can be used in 
combination – an option that can be especially useful to compare new mutations with previously identified ones. 
Prediction of mutational effects on protein function 
By providing simultaneous access to several prediction tools, PRO-MINE renders the ability to obtain 
predictions more efficiently and in comparatively less time than manually combining analysis results from 
different sources. PRO-MINE integrates results from four separately selectable prediction tools (Figure 3b), 
previously described in the Database and Analysis Tools section. 
The results of the selected prediction tools are formatted and displayed in a single table, facilitating the 
comparison of the different predictions. Predictions regarding the TDP-43 mutations core set are pre-computed to 
avoid waiting time. Query results can also be viewed in plain text format or downloaded for further use. 
Additionally to the predictions, for the TDP-43 mutations core set, selecting the mutation identifier opens a new 
window displaying associated information such as clinical data about the patients presenting the mutation, a brief 
description of observed experimental effects of the selected mutation on protein function and the literature 
references reporting the mutation (see Database and Analysis Tools). An example of the results output for five 
mutations is shown in Figure 4. 
It should be stressed out that the validity of in silico predictions should always be assessed by further 
experimental studies. For this reason, when known, observed experimental evidences on the functional 
consequences of the TDP-43 mutations core set were collected and can be easily accessed (as shown in the pop-up 
window in Figure 4). 
The server offers two possibilities of use: the interactive use with results appearing in the web browser which 
will be the choice for most analyses as the computation time is relatively short; and the off-line use with e-mail  
report of the results which is recommended when a long list of mutations is submitted. In the latter case, the results 
will not appear directly on the screen but a link pointing to the results will be sent to the submitted  e-mail address. 
A session identifier is assigned to each submitted job so that the results can be accessed at any time by following 
the link provided in the e-mail. Moreover, the link allows the results to be easily shared with other researchers. 
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Figure 3. Screenshot of the PRO-MINE web server interface. A. Query input panel: mutations can be submitted 
using the text box or by uploading a file; the checkbox must be selected to use the TDP-43 mutations core set. 
B. Section to predict the potential effect of the entered mutations on protein function: the prediction tools can be 
chosen from the list shown; an  e-mail address can be provided to receive the results (this is a recommended 
course of action since some of the predictions require a considerable amount of time to be processed). C. 
Section to display aligned protein sequences from different species with annotated query mutations: a list of the 
possible species to select is provided with the Homo sapiens option being permanently checked; it is also 
offered the possibility to align only amino acid sequences encoded by individual exons by specifying the exons 
numbers in the appropriate text box.  
 E1954  Pinto et al. 
 
 
Figure 4. PRO-MINE output: prediction of mutational effects on protein function. In the table are displayed in 
a comprehensive manner the predictions for five submitted mutations given by NetPhos, PolyPhen, SIFT and 
SNAP. Each row of the table corresponds to the results of all selected web tools for a single mutation. Below 
the table there is a link to view or save the results in plain text format. Selecting a mutation identifier opens a 
pop-up window containing detailed data related to the mutation. 
Protein sequence annotation with mutations 
Multiple alignment of protein sequences from different species provides insight into the level of conservation of 
an amino acid in a sequence position. Conserved positions are commonly associated with functionally important 
sites and disease-related mutations frequently occur in those positions. Based on these considerations, an analytical 
tool that aligns (see Database and Analysis Tools) and displays the TDP-43 protein sequences encoded by the 
TDP-43 gene from different vertebrate species with the submitted mutations annotated was implemented. 
The vertebrate species available include Homo sapiens, Pan troglodytes, Mus musculus, Rattus norvegicus, 
Gallus gallus, Xenopus tropicalis and Danio rerio. The Homo sapiens option is checked by default and cannot be 
unchecked while the other organisms are provided as choices (Figure 3c).  
Alternatively to the complete protein sequence, the amino acid sequences encoded by the individual exons can 
be aligned and displayed separately, in case a more detailed analysis is required. In this case, the ordinal numbers 
of the exons intended to be analysed should be indicated in the appropriate text box (Figure 3c). 
In the output display of the aligned sequences, coloured features are used to annotate the mutations and exon 
boundaries, facilitating data interpretation. Placing the mouse pointer over an annotated mutation produces a 
tooltip with information about the amino acid residues involved and the sequence position where the mutation 
occurs.  
The described functionality offers a layout for a clear visualisation and analysis of protein sequence changes 
among organisms in the positions where mutations occur and the distribution of the mutations along the protein 
sequence. The alignment of the TDP-43 protein sequences from 3 species (Homo sapiens, Pan troglodytes and 
Mus musculus) with the TDP-43 mutations core set annotated is shown as an example in Figure 5. 
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Figure 5. PRO-MINE output: protein sequence annotation with mutations. The aligned TDP-43 protein 
sequences belonging to Homo sapiens, Pan troglodytes and Mus musculus are displayed. Marked in orange 
colour characters are the amino acids involved in the TDP-43 mutations core set. Amino acids located in exons 
boundaries are highlighted in blue or yellow, depending on whether the corresponding codon is part of one or 
two exons, respectively. The rectangular tooltip is produced when the mouse is over a certain mutation and 
displays, in order of appearance: the wild-type amino acid, the position in the protein sequence where the 
mutation occurs and the mutant amino acid involved. 
Future Work 
We plan to continue the development of PRO-MINE by extending it to other proteins and by improving its 
functionalities. 
Like TDP-43, mutations in many other genes have been found to be important in FTLD/ALS and have gained 
the interest from the researchers, such as those identified recently in FUS gene (MIM# 137070) (Lagier-Tourenne 
and Cleveland, 2009), and in the previously identified PGRN (MIM# 138945) (Gijselinck et al., 2008) and SOD1 
genes (MIM# 147450) (Cleveland and Rothstein, 2001). Future work will include expanding the database to cover 
these genes and eventually other genes encoding disease classes of proteins and their disease-associated mutations. 
The database will be updated on a regular basis with newly available data. 
Incorporating links into the results output to supplementary biological sources of relevance in the research of 
mutations is part of the ongoing work. We also plan, having in view the flexibility enhancement of PRO-MINE, to 
provide the possibility to submit not only mutations but also protein sequences as queries. 
Finally, it will also be possible in future updates to expand the list of prediction tools available in PRO-MINE 
as soon as they become publicly available. 
CONCLUSIONS 
PRO-MINE is a high-quality manually curated database of TARDBP gene mutations and a user-friendly web 
tool for the automated analysis of known and novel mutations. 
The developed web tool simplifies and enhances the time-consuming task of assessing the potential effects of 
mutations on protein function by providing simultaneous retrieval and display of predictions from separate web 
tools for a set of submitted mutations. Moreover, up-to-date information as well as visualisation tools are available 
to complement and improve data evaluation. E1956  Pinto et al. 
PRO-MINE is presented here as a proof of concept for derived databases that combine curated datasets with 
analytical tools in a single resource. Therefore, in future installations it is intended to broaden the use of the web 
server by expanding the database to other genes involved in neurodegeneration.  
We expect PRO-MINE to become a valuable tool in the study of disease-associated mutations as there is a 
notable and current increasing interest in the mutation research. 
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